About Mark and David Geier

vaccines_tableFather and son team Mark and David Geier have dedicated their lives to furthering the field of genetics through impactful research. After making a ground-breaking discovery in 1971 concerning the ability of friendly viruses to alter defective genes, Dr. Mark Geier made a name for himself in the field of genetics, and dedicated years of research to furthering his work. In addition to his many publications on gene behavior, Dr. Geier later focused on the dangerous properties of Thimerosal, an organomercury compound present in numerous vaccines administered to children.

His persistent advocacy for his findings, which demonstrated a strong correlation between the receipt of thimerosal and the presence of a number of childhood neurodevelopmental disorders, including autism, was a contributing factor to the CDC’s decision to remove Thimerosal from many vaccines administered in early childhood.

Dr. Geier has published over 150 peer-reviewed articles, book chapters and various other publications, and is a fellow of the American College of Epidemiology.

Dr. Geier’s son, David, followed in his father’s footsteps, earning a degree in Biology from the University of Maryland, Baltimore County (UMBC), and continued his graduate studies at the George Washington University. David’s professional research has also focused on vaccines, specifically their potentially adverse effects. In addition, David and his father are the founders of numerous organizations, including the nonprofit 501c3 Institute of Chronic Illnesses Inc., the nonprofit 501c3 CoMeD Inc., and ASD Centers LLC.